Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?.
Mehta, PA; Emoto, C; Fukuda, T; Seyboth, B; Teusink-Cross, A; Davies, SM; Wilhelm, J; Fuller, K; Vinks, AA; Boulad, F.
Biology of Blood and Marrow Transplantation.
2019;
25:2416-2421.
Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies.
Mehta, PA; Rotz, SJ; Majhail, NS.
Biology of Blood and Marrow Transplantation.
2018;
24:e11-e19.
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
Dvorak, CC; Satwani, P; Stieglitz, E; Cairo, MS; Dang, H; Pei, Q; Gao, Y; Wall, D; Mazor, T; Olshen, AB; et al.
Pediatric Blood and Cancer.
2018;
65:e27034-e27034.
Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study.
Chandra, S; Fukuda, T; Mizuno, K; Davies, SM; Teusink-Cross, A; Tarin, R; Marsh, RA; Vinks, AA; Mehta, PA.
Journal of Antimicrobial Chemotherapy.
2018;
73:1651-1658.
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.
Khandelwal, P; Fukuda, T; Teusink-Cross, A; Kashuba, AD M; Lane, A; Mehta, PA; Marsh, RA; Jordan, MB; Grimley, MS; Myers, KC; et al.
Bone Marrow Transplantation.
2020;
55:1552-1559.
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases.
Kahn, JM; Brazauskas, R; Tecca, HR; Bo-Subait, S; Buchbinder, D; Battiwala, M; Flowers, ME D; Savani, BN; Phelan, R; Broglie, L; et al.
Blood Advances.
2020;
4:2084-2094.
Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients.
van Hoogdalem, MW; Emoto, C; Fukuda, T; Mizuno, T; Mehta, PA; Vinks, AA.
British Journal of Clinical Pharmacology.
2020;
86:933-943.
Association of clinical severity with FANCB variant type in Fanconi anemia.
Jung, M; Ramanagoudr-Bhojappa, R; van Twest, S; Rosti, RO; Murphy, V; Tan, W; Donovan, FX; Lach, FP; Kimble, DC; Jiang, CS; et al.
Blood.
2020;
135:1588-1602.
Chromosome fragility in the buccal epithelium in patients with Fanconi anemia.
Jose Ramirez, M; Minguillon, J; Loveless, S; Lake, K; Carrasco, E; Stjepanovic, N; Balmana, J; Catala, A; Mehta, PA; Surralles, J.
Cancer Letters.
2020;
472:1-7.
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.
Saad, A; Lamb, L; Wang, T; Hemmer, MT; Spellman, S; Couriel, D; Alousi, A; Pidala, J; Abdel-Azim, H; Agrawall, V; et al.
Biology of Blood and Marrow Transplantation.
2019;
25:1875-1883.